Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 1386 (1), 30-44

Reverse Geroscience: How Does Exposure to Early Diseases Accelerate the Age-Related Decline in Health?


Reverse Geroscience: How Does Exposure to Early Diseases Accelerate the Age-Related Decline in Health?

Ronald A Kohanski et al. Ann N Y Acad Sci.


Aging is the major risk factor for both the development of chronic diseases and loss of functional capacity. Geroscience provides links among the biology of aging, the biology of disease, and the physiology of frailty, three fields where enormous progress has been made in the last few decades. While, previously, the focus was on the role of aging in susceptibility to disease and disability, the other side of this relationship, which is the contribution of disease to aging, has been less explored at the molecular/cellular level. Indeed, the role of childhood or early adulthood exposure to chronic disease and/or treatment on accelerating aging phenotypes is well known in epidemiology, but the biological basis is poorly understood. A recent summit co-organized by the National Institutes of Health GeroScience Interest Group and the New York Academy of Sciences explored these relationships, using three chronic diseases as examples: cancer, HIV/AIDS, and diabetes. The epidemiological literature clearly indicates that early exposure to any of these diseases and/or their treatments results in an acceleration of the appearance of aging phenotypes, including loss of functional capacity and accelerated appearance of clinical symptoms of aging-related diseases not obviously related to the earlier event. The discussions at the summit focused on the molecular and cellular relationships between each of these diseases and the recently defined molecular and cellular pillars of aging. Two major conclusions from the meeting include the desire to refine an operational definition of aging and to concomitantly develop biomarkers of aging, in order to move from chronological to physiological age. The discussion also opened a dialogue on the possibility of improving late-life outcomes in patients affected by chronic disease by including age-delaying modalities along with the standard care for the disease in question.

Keywords: AIDS; HIV; aging; cancer; diabetes; geroscience.

Similar articles

  • Disease Drivers of Aging
    RJ Hodes et al. Ann N Y Acad Sci 1386 (1), 45-68. PMID 27943360. - Review
    It has long been known that aging, at both the cellular and organismal levels, contributes to the development and progression of the pathology of many chronic diseases. H …
  • Geroscience and the trans-NIH Geroscience Interest Group, GSIG
    F Sierra et al. Geroscience 39 (1), 1-5. PMID 28299635.
    Age is by far the major risk factor for most chronic diseases. This has been common knowledge since time immemorial. Aging encompasses the biological changes most often s …
  • Advances and Challenges in Geroscience Research: An Update
    A Yabluchanskiy et al. Physiol Int 105 (4), 298-308. PMID 30587027. - Review
    Aging remains the most pervasive risk factor for a wide range of chronic diseases that afflict modern societies. In the United States alone, incidence of age-related dise …
  • Advances in Geroscience: Impact on Healthspan and Chronic Disease
    JB Burch et al. J Gerontol A Biol Sci Med Sci 69 Suppl 1 (Suppl 1), S1-3. PMID 24833579. - Review
    Population aging is unprecedented, without parallel in human history, and the 21st century will witness even more rapid aging than did the century just past. Improvements …
  • Aging and Age-Related Diseases--From Endocrine Therapy to Target Therapy
    Q Bao et al. Mol Cell Endocrinol 394 (1-2), 115-8. PMID 25038521. - Review
    Aging represents an important health issue not only for the individual, but also for society in general. Burdens associated with aging are expanding as longevity increase …
See all similar articles

Cited by 4 PubMed Central articles

MeSH terms